+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Aspergillosis: The most common community-acquired pneumonia with gram-negative Bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease



Aspergillosis: The most common community-acquired pneumonia with gram-negative Bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease



Clinical Infectious Diseases 35(6): 659-664



We retrospectively reviewed all cases of pneumonia that required hospitalization among allogeneic hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) during the period of January 1996 through July 1999. Twelve patients were identified among 88 allogeneic HSCT recipients. All had chronic GVHD and were receiving corticosteroid therapy. Ten of the 12 patients had pulmonary aspergillosis (PA). For 6 of these 10 patients, a gram-negative bacterial pathogen was concurrently isolated from respiratory specimens. At least one-half of the patients with PA had an initial presentation suggestive of bacterial pneumonia; PA was only suspected on the basis of chest CT findings. Aspergillosis is the most common cause of community-acquired pneumonia among allogeneic HSCT recipients with GVHD. CT must be used to exclude an underlying fungal cause in patients who present with a gram-negative pneumonia.

(PDF emailed within 0-6 h: $19.90)

Accession: 010204946

Download citation: RISBibTeXText

PMID: 12203161

DOI: 10.1086/342061


Related references

Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients. Brazilian Journal of Medical and Biological Research 42(3): 289-293, 2009

Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients. General Dentistry 59(6): 458-62; Quiz 463-4, 2012

Factor XIII replacement in graft versus host disease of the bowel in stem cell transplant recipients. Blood 96(11 Part 1): 400a, November 16, 2000

Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients. Transplantation Proceedings 34(7): 2922-2924, 2002

Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality. Journal of Clinical Oncology 17(3): 806-812, 1999

The effect of graft-versus-host disease on skin endothelial and epithelial cell chimerism in stem-cell transplant recipients. Transplantation 87(7): 1096-1101, 2009

Risk factors for acute graft-versus-host disease in allogeneic blood stem cell transplant recipients. Blood 90(10 SUPPL 1 PART 1): 101A, Nov 15, 1997

Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. PharmacoTherapy 27(12): 1627-1636, 2007

Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients. American Journal of Dermatopathology 37(7): 523-529, 2016

Ex vivo T-cell depletion for graft versus host disease prophylaxis in related haplo-identical allogeneic stem cell transplant recipients. Blood 96(11 Part 2): 362b-363b, November 16, 2000

Chronic graft-versus-host disease following varicella-zoster virus infection in allogeneic stem cell transplant recipients. International Journal of Hematology 78(4): 370-373, 2003

Antibodies to 70 kD and 90 kD heat shock proteins are associated with graft-versus-host disease in peripheral blood stem cell transplant recipients. Clinical & Experimental Immunology 127(3): 553-559, March, 2002

Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients. Plos One 12(9): E0185210-E0185210, 2017

Community-Acquired Pneumonia Due to Gram-Negative Bacilli. Clinical Pulmonary Medicine 8(1): 5-12, 2001

Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplantation 26(8): 871-876, October 2, 2000